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Recently, Simon et al. (38) using positional cloning, have identified a human gene, hPCLN-1 (also known as CLDN16, NCBI accession no. NM-006580), mutations in which cause familial hypomagnesemia-hypercalciuria syndrome. hPCLN-1 consists of five exons and resides on chromosome 3q27. The gene encodes a protein, paracellin-1, which is composed of 305 amino acids (38) . Northern blot analysis of human tissues has shown that the 3.5-kb PCLN-1 mRNA transcript is expressed exclusively in the kidney (38) . RT-PCR analysis of mRNA from nephron segments of the rabbit (38) and rat (42) has demonstrated that PCLN-1 is expressed in the TAL and the distal convoluted tubule (DCT). The paracellin-1 protein, which is located in the paracellular tight junctions of the TAL and DCT, is a member of the claudin family of tight junction proteins (27) and appears to mediate resorption of both Mg 2ϩ and Ca 2ϩ (38) . In the kidney, the specialized reabsorptive and/or secretory function of each tubule segment depends upon its structural arrangement and upon the specific pattern of gene expression in each tubular cell type. The promoters of several transporter and channel genes including aquaporin (28), the Na ϩ -phosphate cotransporter (36) , the Na ϩ -K ϩ -Cl Ϫ cotransporter (39), and chloride channels (40) as well as the promoters of nephrin (46) and cadherin (13, 43) genes have been cloned and shown to direct kidney-specific expression in vitro and/or in transgenic mice. Several transcription factors including myc-associated zinc finger proteins and Krüppel-like factor (41), hepatocyte nuclear factor-3 (39) , and hepatocyte nuclear factor-1␤ (2), were found to be involved in kidney-specific expression of the ClC-K1 chloride channel, thiazide-sensitive Na-Cl cotransporter, and cadherin genes, respectively. However, very little is known about the regulatory elements responsible for cell-specific expression of transporter and channel genes in the kidney. As yet, the promoter region of the human paracellin-1 gene has not been characterized, and the molecular mechanisms for renal epithelial-specific activity of this gene have not been investigated.
Many factors are known to modulate Mg 2ϩ reabsorption in various nephron segments. These factors include hormones such as insulin, 1,25(OH) 2 vitamin D, aldosterone, and parathyroid hormone as well as nonhormonal factors such as Mg 2ϩ restriction and load and acid-base changes (8, 30) . Most of these factors influence both transcellular magnesium transport in the DCT as well as paracellular transport of this cation in the TAL (8, 30 transport at the transcriptional level, probably via the peroxisome proliferator response element (PPRE) contained within the 70-bp region.
MATERIALS AND METHODS
Opossum kidney (OK) cells (provided by Dr. J Green, Technion, Haifa, Israel), human embryonic kidney (HEK293) cells (provided by Dr. K. Skorecki, Technion, Haifa, Israel), mouse distal convoluted tubule (MDCT) cells (provided by Dr. P. Friedman, University of Pittsburgh, Pittsburgh, PA), and mouse embryonic fibroblast (NIH3T3) cells were grown and maintained in DMEM/F-12 supplemented with 10% fetal calf serum, 2 mM glutamine, 50 IU/ml penicillin, and 50 g/ml streptomycin at 37°C in a humidified atmosphere of 95% air-5% CO 2.
RT-PCR followed by Southern blot analysis. Total RNA isolated with Tri-reagent (MRB, Cincinnati, OH) from the cell lines mentioned above was reverse-transcribed using OmniscriptRT (Qiagen, Hilden, Germany) with random hexamers (Promega, Madison, WI). PCR was performed using HotStarTaq DNA polymerase (Qiagen) with two sets of primers (Table 1 ). The first (F1,R1) complementary to exon 1 of hPCLN-1 and the second (F2,R2) complementary to a region between exons 3 and 5 of PCLN-1 (spanning two introns) highly homologous among human, rat, and mouse (mPCLN-1). The resultant DNA was separated on 1% agarose gels and transferred to nylon membranes (Osmonics, Minnetonka, MN). The membranes were probed with PCLN-1 cDNA probes generated by PCR using primers F1,R1 for hPCLN-1 and primers F3,R2 (Table 1 ) from exon 5 for mPCLN-1, with human genomic DNA as a template. A similar procedure was carried out with actin primers (F4,R4) as control. Probes were 32 P labeled by random priming (Biological Industries, Beit Ha'Emek, Israel) using [␣- Western blot analysis. Protein extracts from HEK293, OK, and NIH3T3 cells were prepared using standard protocols (35) . Proteins were separated on 10% SDS polyacrylamide gels, transferred to nitrocellulose membranes (Schleicher and Schuell, Dassel, Germany), and probed with anti-human paracellin-1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) using chemiluminescense (Biological Industries). To verify antibody specificity, a peptide competition assay was carried out with 100-fold excess of paracellin-derived peptide.
Cloning of hPCLN-1 5Ј-flanking DNA. Using the published sequence of human paracellin-1 cDNA (NCBI accession no. NM-006580), we localized the hPCLN-1 gene on chromosome 3, drafts of which have recently been deposited in NCBI (accession no. NT-00962). A DNA fragment of 7.5 kb in the 5Ј-flanking sequence region, to but not including the PCLN-1 translation start site (Fig. 1) , was synthesized using PCR with human genomic DNA as a template and primers F5/R5 (Table 1) . To minimize the possibility of PCR-generated mutations, the High-Fidelity Long-Range PCR system (Roche, Mannheim, Germany) was used. The fragment was TA cloned into pCR-XL-TOPO vector (Invitrogen, Carlsbad, CA) and sequence verified. Computer analysis (Wisconsin Package version 8.0, Genetic Computer Group) of the 5Ј-flanking region of hPCLN-1 from the gene's translation start site was carried out, and putative transcription factor binding sites were identified.
Generation of promoter/reporter constructs. The 7.5-kb 5Ј-flanking sequence described above was subcloned into pGL3-basic vector (Promega) upstream of a luciferase reporter gene (and named pJ12) (Fig. 1) . In addition, a set of seven deletion fragments decreasing in size from the 5Ј-end of the 7,514-bp genomic fragment were produced and cloned into pGL3-basic vector. Five inserts were prepared using PCR-based strategies with genomic DNA as template with primers F6, F7, F8, F9, F10, and R5 ( Table 1 ). The additional two were prepared by removing specific 5Ј-segments from cloned hPCLN-1 sequences in pGL3-basic, using restriction enzymes. All eight constructs were sequenced to verify the orientation and integrity of the inserts. As illustrated in Fig. 1 , the 5Ј-ends of the deletion fragments were positioned at Ϫ4687 (pJ2L), Ϫ3986 (pJ2/3.9), Ϫ3317 (pJ2/3.3), Ϫ2554 (pJ2M), Ϫ1982 (pJ2/1.9), Ϫ1458 (pJ2.1/4), and Ϫ733 (pJ2.7), respectively. All fragments extended to the ATG site, but did not 
See text for details.
include it. All eight constructs were cloned into the vector in sense orientation, and the 2.5-kb fragment in pJ2M was also cloned in antisense orientation.
A reporter plasmid containing a 586-bp nested deletion (from position Ϫ1772 to Ϫ1186) within this 2.5-kb DNA region (termed pJ2Mdel) was generated using PCR with pJ2M as template and primers F12/R12 (Table 1) complementary to the gap ends. Following DpnI treatment, the PCR-generated pGL3-basic construct was ligated, and the sequence was verified. Empty pGL3 vector containing no insert was used as a negative control. pGL3-control containing the SV40 enhancer/promoter was used as a positive control. Promoter activity was estimated from the ratio of hPCLN-1-driven luciferase activity in pGL3-basic vector to promoterless pGL3-basic vector.
For reporter gene activity driven by distal hPCLN-1 promoter fragments, the DNA region from position Ϫ1738 to Ϫ1493 as well as a series of five deletion fragments 5Ј-truncated in increments of 35 bp were PCR generated with human genomic DNA and primers F13, F14, F15, F16, F17, F18, with R13. All six fragments were cloned into the pGL3-promoter vector, which carries an SV40 minimal promoter upstream to the luciferase reporter gene. In these experiments, promoter activity was determined from the ratio of hPCLN-1 promoterdriven luciferase activity in the pGL3-promoter vector to that in the empty pGL3-promoter vector.
Point mutations in the 2.5-kb insert-containing plasmid, pJ2M, and the 210-bp insert-containing plasmid, pJ210 (see RESULTS), were generated using PCR with the mutated primers F19 and R14 (Table 1) .
In all transfection experiments, plasmid pCH110 (Pharmacia, Uppsala, Sweden), containing the LacZ gene driven by the CMV promoter, was used to normalize for transfection efficiency. DNA for transfections was purified using Nucleobond AX (Macherey Nagel, Duren, Germany).
Transient transfections and reporter gene assays. OK, HEK293, and MDCT cells were plated (5 ϫ 10 4 /dish) in 24-well dishes in serum-containing medium. Cotransfections were performed using Fugene 6 (1.2 l/well, Roche) with 0.3 g reporter plasmid and 0.3 g pCH110. NIH3T3 cells (4 ϫ 10 5 /dish) were seeded in 6-well plates and incubated overnight at 37°C. Cells were transfected 24 h later using Polyfect (10 l/well, Qiagen) with 0.75 g reporter plasmid and 0.75 g pCH110. All plates were incubated at 37°C for 48 h. For enzymatic assays, cells were washed with PBS (150 mM NaCl, 15 mM sodium phosphate, pH 7.3) and lysed by incubating in 200 l/well M-Per (Pierce, Cheshire, UK) for 5 min at 37°C. Lysed cells were centrifuged, and the supernatant was aliquoted (50 l/well) into 96-well plates. Fifty microliters of Luciferase Assay Reagent (Promega) were automatically added, and the light intensity of the reaction was immediately read in a luminometer (Lucy, Anthos, Austria) for a period of 10 s. Luciferase activity was normalized to ␤-galactosidase activity, which was measured in identical cell lysates. One hundred sixty microliters of ONPG substrate (Sigma, St. Louis, MO) were added to 30 l of cell lysate in each well of a 96-well plate. The reaction mixture was incubated for 30 min at 37°C, or until yellow color developed. ␤-Galactosidase measurements were performed by a luminometer with a 405-nm filter. Measurements of luciferase and ␤-galactosidase were performed in duplicate.
In some experiments, 48 h after transfection, the medium was replaced with fresh medium containing 0 (low), 0.7 (normal), or 1.5 mM (high) Mg 2ϩ (Biological Industries). In other experiments, the fresh medium contained 1,25(OH)2 vitamin D (from a stock solution of 10 Ϫ4 M in ethanol, Sigma) at a final concentration of 5 ϫ 10 Ϫ7 M. Control experiments were carried out with 0.5% ethanol. Cells were exposed to experimental media for 24 h.
EMSA. Nuclear extracts were prepared from cells using the method of Dignam (9) . Briefly, confluent cells were grown on 100-mm plates, washed in 3 ml of PBS (150 mM NaCl, 15 mM sodium phosphate, pH 7.3) supplemented with protease inhibitor mix (Complete, Roche), scraped, and pelleted. The pellet was resuspended in ice-cold lysis buffer (in mM: 10 HEPES, pH 7.9, 1.5 MgCl2, 420 NaCl, 0.2 EDTA, and 1 DTT as well as protease inhibitor mix) and incubated at 4°C for 20 min. Following centrifugation, the supernatant, containing the nuclear extract, was diluted 1:2 with (in mM) 20 HEPES (pH 7.9), 100 KCl, 0.2 EDTA, and 1 DTT as well as 20% glycerol and protease inhibitors. Protein concentration was measured using Bradford reagent (Sigma) at 595 nm with bovine serum albumin as the standard. Double-stranded oligonucleotides corresponding to promoter sequences of interest were end-labeled with [␥-32 P]ATP (DuPont-New England Nuclear) using T4 polynucleotide kinase (NEB, Beverly, MA). Binding reactions contained (in mM) 10 Tris ⅐ HCl (pH 8.0), 250 KCl, 0.5 EDTA, and 0.2 DTT as well as 0.1% Triton-X 100, 12.5% glycerol (vol/vol), 1 g poly-dIdC-labeled probe (5 ϫ 10 4 counts/ min), and 50 g of nuclear extracts. In some reactions, a 50-fold molar excess of unlabeled double-stranded oligonucleotide was added for specific competition. Following a 30-min incubation period on ice, complexes were resolved on 4% nondenaturing polyacrylamide gels in 1ϫ TBE buffer. The gels were dried and autoradiographed.
RESULTS

Cloning the 5Ј-flanking region of hPCLN-1.
A DNA fragment stretching over 7.5 kb in the 5Ј-flanking region of hPCLN-1, reaching 9 bp from the gene's translation start site, was isolated. Computer analysis of this fragment disclosed a variety of putative transcription factor binding sites, among them recognition sites for several transcription factors known to be tissue restricted and expressed in the kidney. These included hepatocyte nuclear factor 5 (HNF-5), GATA factors, and a peroxisone proliferator-activated receptor (PPAR) binding site. The hPCLN-1 promoter also contained binding sites for transcription factors involved in signal transduction, such as activator protein (AP)-1 and AP-3 as well as a putative TATA box.
The 5Ј-flanking regions of PCLN-1 in mouse and rat genomic DNA were located using NCBI-BLAST with the respective cDNA sequences. Comparison of the 5Ј-flanking region of hPCLN-1 to that in mouse (accession no. NW-000107, region: 23187252 . . . 23287252) and rat (accession no. AC106700) revealed very little overall sequence identity within 2.4 kb 5Ј to the translation site. However, the 51-bp region from position Ϫ392 to Ϫ341, relative to the hPCLN-1 translation start site, was 79 and 81% identical to the mouse and rat PCLN-1 5Ј-flanking region sequences, respectively.
Comparison of the hPCLN-1 5Ј-flanking region to that of a variety of genes encoding various ion channels and transporters, known to be specifically expressed in the kidney, such as the voltage-gated Cl Ϫ channels ClC-K1 and ClC-K2, aquaporin-2, the K ϩ channel ROMK, Tamn-Horsfall protein, and the thiazide-sensitive NaCl cotransporter, did not reveal areas of sequence homology.
Kidney cell-specific expression of hPCLN-1. RT-PCR followed by Southern blot analysis with nested probes (see MATERIALS AND METHODS) detected endogenous PCLN-1 mRNA in HEK293 and OK cells using an hPCLN-1 probe and in HEK293 and MDCT cells using an mPCLN-1 probe ( Fig. 2A) . Paracellin-1 mRNA was not detected in NIH3T3 cells.
Western blot analysis with paracellin-1-specific antibody detected paracellin-1 protein expression in HEK293 and OK but not in NIH3T3 cells (Fig. 2B) . Addition of 100-fold molar excess of paracellin-1 peptide to the antibody, 24 h before incubation with the blot, competed out the paracellin-1 band (data not shown).
Kidney cell-specific activity of the hPCLN-1 promoter. To verify that the 5Ј-flanking region of PCLN-1 contained a functional cell-specific promoter, reporter gene assays were conducted. The 7.5-kb hPCLN-1 5Ј flanking region, as well as three 5Ј-deletion products, were cloned upstream to a luciferase reporter gene in promoterless pGL3-basic vectors in sense orientation.
The resulting plasmids ( Fig. 1) , designated pJ12 (7,514-bp insert), pJ2L (4,687-bp insert), pJ2M (2,554-bp insert) and pJ2.7 (733-bp insert), were transfected into the PCLN-1-ex- Fig. 1 ). Luciferase activity was measured after 48 h. To control for transfection efficiency, cells were cotransfected with 0.3 g (0.75 g for NIH3T3) pCH110, and luciferase activity was normalized to ␤-galactosidase activity. Activity of reporter plasmids is expressed as %pGL3-basic vector activity. Values are means Ϯ SE of 3-5 independent experiments, each performed in quadruplicate. OK, opossum kidney; MDCT, mouse distal convoluted duct.
pressing cell lines HEK293, OK, and MDCT. Reporter gene activities were compared with those in transfected NIH3T3 cells, which do not express PCLN-1. As shown in Fig. 3 , all three PCLN-1-expressing renal cell lines displayed a similar pattern of luciferase activity when transfected with pJ12, pJ2L, pJ2M, and pJ2.7. Luciferase activity was maximally induced by pJ2M (2.5 kb) and gradually diminished, as the insert size was either increased or decreased. Specifically, the lowest luciferase activity resulted from transfection of the 7.5-kb insert-containing plasmid (pJ12). Truncation of the 5Ј-flanking region from Ϫ7,514 to Ϫ4,687 bp (pJ2L) did not significantly increase luciferase activity. A further decrease in size from Ϫ4,687 to Ϫ2554 bp (pJ2M) caused a significant increase in luciferase activity in all three renal cell lines. When the 7.5-kb fragment in the luciferase vector was further shortened to 0.733 kb (pJ2.7), luciferase activity in all four renal cell lines was markedly reduced. Transfection of each of the four constructs into the control cell line NIH3T3 showed negligible induction of luciferase activity.
Taken together, these results indicated that the 2.5-kb hP-CLN-1 promoter fragment cloned in pJ2M contained an active promoter. The lack of stimulation in NIH3T3 cells suggested that the activity of the hPCLN-1 promoter was kidney cell specific. The results also suggested that kidney-specific expression of the hPCLN-1 promoter was due, at least in part, to tissue-specific transcriptional regulation.
Although Deletion analysis of the hPCLN-1 promoter. To further explore the 5Ј-flanking region of hPCLN-1, a second set of deletion constructs was tested (Fig. 1) , two between pJ2L and pJ2M (designated pJ2/3.9 and pJ2/3.3) and two between pJ2M and pJ2.7 (designated pJ2/1.9 and pJ/1.4). All eight constructs were transiently transfected into OK and NIH3T3 cells. As evident from Fig. 4 , the highest level of luciferase activity resulted from transfection of the 2.5-kb insert-containing plasmid (pJ2M). Increasing the size of this fragment by 763 bp (pJ2/3.3) caused a 50% reduction in luciferase activity, which remained unchanged when the 2.5-kb fragment was lengthened by 1,432 bp (pJ2/3.9). When the 2.5-kb fragment was lengthened by 2,133 (pJ2L) or 4,960 bp (pJ12), luciferase activity gradually diminished by 60 and 90%, respectively, compared with pJ2M. Decreasing the size of the 2.5-kb fragment by 572 (pJ2/1.9) and 1,096 bp (pJ2/1.4) brought about a 30 and 77% reduction in luciferase activity, respectively. A further truncation of the insert from 1,458 to 733 bp left luciferase activity at 23% that of pJ2M. No significant differences in luciferase activity between the various fragments tested were demonstrated in control NIH3T3 cells (data not shown).
To further explore the 2.5-kb 5Ј-flanking region of hPCLN-1, which displayed the highest promoter activity, an orientation study was performed in OK cells. As shown in Fig.  5 , when the 2.5-kb promoter fragment in pGL3 vector was reversed (pJ235M), luciferase activity was 80% lower than activity induced by the same sequence in sense orientation (pJ2M). Fig. 1 ). Luciferase activity was measured after 48 h. To control for transfection efficiency, cells were cotransfected with 0.3 g pCH110, and luciferase activity was normalized to ␤-galactosidase activity. Activity of reporter plasmids is expressed as %pGL3-basic vector activity. Values are means Ϯ SE of 3-5 independent experiments, each performed in quadruplicate. Taken together, these results suggested that a positive regulatory element, most likely located between positions Ϫ1982 and Ϫ1458, and a negative regulatory element likely positioned between positions Ϫ3317 and Ϫ2554, are involved in hPCLN-1 promoter activity in renal cells.
Binding of nuclear proteins to the hPCLN-1 promoter. To investigate the location and nature of the presumed positive regulatory element between positions Ϫ1982 and Ϫ1458, binding of nuclear proteins to this region was examined. The 525-bp DNA fragment was divided into 15 sequential doublestranded oligonucleotides, which were 5Ј end-labeled with 32 P and incubated with nuclear proteins. DNA-protein complexes were resolved from unbound DNA by nondenaturing gel electrophoresis. Binding patterns were compared between nuclear extracts from OK cells and those from control NIH3T3 cells. As shown in Fig. 6 , incubation of seven sequential DNA fragments located in the proximal part of the 525-bp sequence (between positions Ϫ1770 and Ϫ1491) with nuclear extracts from OK cells produced several retarded bands (ଙ in Fig. 6 ) that were absent when the DNA was incubated with nuclear extracts from NIH3T3 cells. Binding was specific, since addition of a 50-fold molar excess of unlabeled oligonucleotide abolished DNA-protein complexes. DNA binding was absent in lanes without the nuclear extract. When oligonucleotides originating from the distal part of the 500-bp region (from position Ϫ1982 to Ϫ1771) were incubated with nuclear proteins from OK and NIH3T3 cells, the protein-DNA binding pattern was similar in the two cell lines (data not shown).
Taken together, these results suggested that OK cells, the renal cell line OK, but not nonrenal NIH3T3 cells, contain nuclear proteins that bind specifically to the hPCLN-1 promoter in the 280-bp region between positions Ϫ1770 and Ϫ1491.
Deletion analysis of the DNA region containing the proposed positive regulatory element of hPCLN-1. To investigate the functional importance of the 280-bp hPCLN-1 promoter region implicated in transcriptional activation and nuclear protein binding, a deletion of the region between positions Ϫ1772 and Ϫ1186 within the pJ2M reporter vector was created. When the resulting plasmid, designated pJ2Mdel, was transfected into OK cells, luciferase activity was reduced by 60% relative to pJ2M (Fig. 7A) .
To further define the positive regulatory element within the 280-bp promoter sequence of functional importance, deletion analysis of this segment was carried out. The hPCLN-1 promoter sequence from positon Ϫ1738 to Ϫ1493 was 5Ј-truncated in increments of 35 bp. These progressively shorter DNA fragments were cloned upstream to a luciferase reporter gene in SV40 minimal promoter-containing vectors, pGL3-promoter, and transfected into OK cells. Figure 7B illustrates that luciferase activity was highest with the construct containing the hPCLN-1 promoter sequence from position Ϫ1703 to Ϫ1493. Truncation of the promoter to position Ϫ1668 caused little change in reporter activity. However, when the promoter was truncated to position Ϫ1633, reporter activity diminished by 50%. Two more sequential 35-bp deletions caused only minor reductions in luciferase activity.
Taken together, these experiments suggest that the 70-bp DNA sequence between positions Ϫ1703 and Ϫ1633, which binds nuclear proteins from renal cells, contains a positive regulatory element involved in transcriptional activation. Computer analysis of this segment, revealed a single PPRE at position Ϫ1655, which is known to bind the transcription factor PPAR (11, 15, 20) .
Most PPREs described so far consist of a direct repeat of two hexamer half-sites separated by several nucleotides (14) . The first half-site is highly conserved (AGGTCA) whereas the second is not. The sequence of the PPRE identified in the hPCLN-1 promoter contains one half-site, which is a perfect consensus sequence, but no clearly recognizable second halfsite. This sequence, however, has been shown to enable transcription factor binding and activation (3) .
Several in vivo (37, 44) and in vitro (7, 30) studies have demonstrated that Mg 2ϩ restriction increases Mg 2ϩ transport in the renal tubule whereas Mg 2ϩ load decreases it (22, 31) . To explore the molecular mechanisms of this modulation, we examined the effect of changes in ambient Mg 2ϩ concentration on the activity of the hPCLN-1 promoter. For this purpose, OK cells were transiently transfected with the 2.5-kb hPCLN-1 promoter fragment (pJ2M) driving maximal luciferase activity. Following transfection, the cells were exposed for 24 h to media containing 0 (low), 0.7 (normal), or 1.5 mM (high) Mg 2ϩ . As demonstrated in Fig. 8 hPCLN-1 promoter. Since the vitamin D receptor (VDR) and PPAR both belong to the nuclear receptor superfamily of transcription factors and thus share several biological characteristics (6, 15, 26) , we examined the effect of 1,25(OH) 2 vitamin D on the hPCLN-1 promoter sequence containing the PPRE half-site. We first examined the action of 1,25(OH) 2 vitamin D on the 2.5-kb hPCLN-1 promoter fragment (pJ2M). For this purpose, OK cells, transiently transfected with this fragment were exposed to 5 ϫ 10 Ϫ7 M 1,25(OH) 2 vitamin D for 16 -20 h, which caused promoter activity to decrease by 56% (Fig. 9A) . Experimental conditions were selected based on preliminary experiments with varying 1,25(OH) 2 vitamin D concentrations (10 Ϫ6 to 10 Ϫ7 M) (data not shown).
We next examined whether the effect of 1,25(OH) 2 vitamin D on the promoter was PPRE dependent. For this purpose, OK cells transfected with pGL3-promoter vector containing a 210-bp hPCLN-1 promoter fragment (pJ210) corresponding to the hPCLN-1 promoter sequence between positions Ϫ1703 and Ϫ1493 harboring the PPRE site, or a 70-bp 5Ј deletion product (pJ140) of this same promoter sequence, between positions Ϫ1633 and Ϫ1493, lacking the PPRE, were exposed to 1,25(OH) 2 vitamin D under similar conditions. 1,25(OH) 2 vitamin D treatment reduced the activity of the PPRE-containing promoter fragment by 52% compared with control non-1,25(OH) 2 vitamin D-treated cells (Fig. 9B ). This effect of 1,25(OH) 2 vitamin D was markedly diminished in cells transfected with the PPRE-lacking fragment. Moreover, the actual difference in promoter activity between the PPRE-containing and PPRE-lacking fragments decreased fivefold following 1,25(OH) 2 vitamin D treatment (Fig. 9B) .
To further establish the role of PPRE in hPCLN-1 promoter activity, three bases of the PPRE half-site were point-mutated in both pJ2M and pJ210. OK cells transfected with these constructs were exposed to 1,25(OH) 2 vitamin D as above. As shown in Fig. 10A , the decrease in pJ2M activity following 1,25(OH) 2 vitamin D treatment was greatly diminished in cells transfected with the mutated promoter. When a similar experiment was carried out with mutated pJ210 (Fig. 10B) , the 1,25(OH) 2 vitamin D-induced reduction in luciferase activity seen in cells transfected with wild-type, PPRE-containing pJ210 was completely abolished once the PPRE site was mutated.
These experiments suggest that 1,25(OH) 2 vitamin D modulates hPCLN-1 activity by a mechanism that appears to involve the PPRE half-site in the gene promoter.
DISCUSSION
In this study, we describe the transcriptional analysis of the promoter of the human paracellin-1 gene. We demonstrate that a 70-bp region between positions Ϫ1633 and Ϫ1703 may play a key role in the activity of the hPCLN-1 promoter (Figs. 6 and  7) . Furthermore, we provide evidence that an interplay between a positive regulatory element located within this 70-bp region, and a more distally located negative regulatory element on the 5Ј-flanking region of the paracellin-1 gene, may determine renal cell-specific expression of this gene (Fig. 4) . In addition, we demonstrate that ambient Mg 2ϩ concentration affects hPCLN-1 promoter activity (Fig. 8) . Finally, we show that 1,25(OH) 2 vitamin D modulates hPCLN-1 promoter activity via this 70-bp, PPRE-containing, hPCLN-1 promoter fragment (Figs. 9 and 10) , thereby suggesting that paracellin-1 gene expression is subject to PPAR/PPRE-mediated transcriptional regulation by this hormone.
Reabsorption of solutes across the tubular epithelial layer depends on two separate routes: a transcellular pathway and a paracellular pathway (1, 47) . The paracellular pathway is regulated by tight junctions, which form a barrier to the diffusion of solutes across epithelial cells and function as a boundary between the apical and basolateral membranes maintaining epithelial cell polarity (21) . Paracellin-1, which appears to regulate the paracellular transport of Mg 2ϩ in the TAL, is the first tight junction protein reported to be involved in ion resorption (38) . Paracellin-1, or claudin 16, (38) belongs to the claudin family of proteins that participate in the formation of tight junction strands in various tissues (27) and are thought to have a major role in regulating the magnitude and nature of paracellular permeability (1) . The disease mutations found in paracellin-1 in familial hypomagnesemia-hypercalciuria syndrome result in an increased resistance to the electrical seal of tight junctions, thereby decreasing epithelial ionic permeability and selectively impeding magnesium and calcium reabsorption (38, 47) . Recently, it has been reported that deletion of the paracellin-1 gene is responsible for renal tubular dysplasia in cattle (29) . This finding suggests that paracellin-1, in addition to its function in ion resorption, may play an important role in the normal development and organization of the renal tubule.
hPCLN-1 mRNA was found to be expressed exclusively in the kidney (38, 42) . Although cis-acting regulatory elements involved in regulating gene transcription may be dispersed throughout the gene locus, often the proximal promoter region contains elements sufficient for high levels of tissue-specific gene transcription. These elements may function as binding sites for tissue-restricted proteins that arbitrate transcriptional activation in expressing cells. In an effort to identify cis-acting elements involved in regulating kidney-specific expression of hPCLN-1, we focused our study on the 5Ј-flanking region of this gene. We isolated a 7.5-kb genomic sequence corresponding to the 5Ј-flanking region of hPCLN-1 and, using reporter gene assays, showed that the proximal 2.5-kb region contained cis-acting, positive and negative, regulatory elements that play a role in renal epithelial-specific expression of hPCLN-1. This promoter displayed high activity in PCLN-1-expressing renal cell lines but not in the fibroblast cell line NIH3T3. In the rabbit (38) and rat (42) kidney, PCLN-1 expression has been shown to be restricted to the TAL and the DCT. Several renal cell lines were used in this study. These included HEK293 and MDCT cells, as well as OK cells of proximal tubular origin. These renal cells were shown to express paracellin-1 mRNA ( Fig. 2A) and protein (Fig. 2B) and to display hPCLN-1 promoter-driven luciferase activity (Fig. 3) as opposed to mouse embryonic fibroblast cells (NIH3T3), which demonstrated no expression/activity, indicating that the PCLN-1 promoter was kidney specific.
In our study, OK cells displayed the highest level of hPCLN-1 promoter-driven reporter gene activity (Fig. 3) . Hence, these cells served as the recipient cells in most of our transfection experiments. It is not entirely clear why OK cells of proximal tubular origin express paracellin-1, which was found only in the TAL and the DCT of the rabbit and the rat. Several considerations could provide an explanation for this finding. First, the nephron segment-specific expression of the paracellin-1 gene has been examined in the kidney of these two rodents only. It is possible that the expression of the paracellin-1 gene in other animals and species, including humans, extends to the tight junction of more proximal nephron segments. Second, although several properties of OK cells are consistent with a proximal tubular site of origin, this cell line was originally derived from the whole kidney and may possess characteristics of more distal regions of the nephron (10, 19) . Finally, in the immature rat, Mg 2ϩ reabsorption occurs predominantly via the paracellular pathway in the proximal tubule rather than in the loop of Henle (23, 30) . It is possible that the OK cell line used in our study contains cells with characteristics of the immature proximal tubule, including expression and cell-specific activity of genes, such as PCLN-1, participating in Mg 2ϩ reabsorption in the immature proximal tubule tight junction. Taken together, we believe that the expression of paracellin-1 mRNA and protein in OK cells, coupled with the marked increase in reporter gene activity driven by the hPCLN-1 promoter in this cell line, has made OK cells suitable as experimental cells in our study.
Deletion analysis of reporter gene constructs containing hPCLN-1 promoter DNA suggested that hPCLN-1 transcription may be regulated by a proximal positive regulatory element positioned between Ϫ1982 and Ϫ1458 and a more distally located negative regulatory element between positions Ϫ3317 and Ϫ2554 (Fig. 4) . EMSA studies of the presumed positive regulatory element-bearing region indicated that OK cells contain nuclear proteins that bind specifically to this functionally important region of the hPCLN-1 promoter (Fig.  6 ). NIH3T3 nuclear proteins did not bind to this DNA region. These proteins are potentially involved in tissue-specific expression of hPCLN-1. When this protein-binding DNA region was deleted from the 2.5-kb PCLN-1 promoter, a 60% reduction in promoter activity occurred. Detailed analysis revealed a 70-bp sequence within this DNA region, which seems to be responsible, at least in part, for modulating kidney-specific hPCLN-1 transcription (Fig. 7) . Computer analysis of this segment disclosed a single PPAR binding site (PPRE).
Tubular Mg 2ϩ reclamation is modulated by a variety of hormonal and nonhormonal factors (8, 16, 30 (18) and, as discussed above, appear to express the paracellin-1 gene as well as possess the machinery necessary for its activity. Hence, this cell line may serve as an excellent model with which to explore the effect of this hormone on the paracellin-1 gene. Taken together, our findings provide the first direct evidence that paracellular, paracellin-1-mediated Mg 2ϩ transport may be regulated at the transcriptional level by 1,25(OH) 2 vitamin D. However, the physiological significance of the transcriptioninhibiting effect of 1,25(OH) 2 vitamin D shown in our study and its role in overall magnesium transport in the renal tubule remain to be clarified.
The effect of 1,25(OH) 2 vitamin D on the hPCLN-1 promoter was demonstrated in our study to involve the PPRE half-site located between positions Ϫ1633 and Ϫ1703 within this promoter (Figs. 9 and 10) . The PPARs comprise a group of transcription factors that belong to the nuclear receptor superfamily to which the VDR, the thyroid hormone receptor, and the all-trans-retinoic acid receptor also belong (11, 15, 20) . PPARs are ligand-regulated transcription factors that control gene expression by binding to specific response elements (PPREs) within promoters, having formed heterodimers with the retinoid X receptor (11, 15, 20) . Three PPAR isoforms, PPAR␣, PPAR␤, and PPAR␥, have been identified (11, 15) and are expressed in several tissues including the kidney (11, 48) . PPARs participate in a variety of biological processes common to various cell types, including lipid metabolism, glucose homeostasis, inflammation, cell proliferation and differentiation, apoptosis, and early development (4, 11) . However, despite their abundant expression in various segments of the renal tubule (11, 48) , very little is known about specific tubular transport processes that are controlled by the PPARs. Noteworthy is a recent study demonstrating enhanced renal tubular cell surface expression of the epithelial sodium channel in response to PPAR activation (12) .
In our study, we focused on 1,25(OH) 2 vitamin D, known to modulate Mg 2ϩ transport on one hand (30, 32) and to interact with the PPAR system on the other. The DNA binding site of the VDR is 46% homologous to the DNA binding site of PPAR, and both receptors are known to heterodimerize with the retinoid X receptor before binding to their specific DNA motifs (6, 15, 26) . However, recent studies suggest that there is considerable flexibility in the binding sites recognized by the VDR, including the existence of some single half-sites (17) . Furthermore, the outcome of the interaction between the VDR and its binding site may be an increase (5) or a decrease (25) in gene transcription. Of note is a recent study demonstrating that the VDR represses transcriptional activity of PPAR␣ in COS1 cells (34) . In our study, we provide evidence for PPREdependent transcriptional regulation of hPCLN-1 by 1,25(OH) 2 vitamin D, and we show here, for the first time, that the PPAR/PPRE axis may play a specific role in the hormonal regulation of Mg 2ϩ transport in the renal tubule. In conclusion, an interplay between a positive regulatory element and a more distally located negative regulatory element on the 5Ј-flanking region of the paracellin-1 gene may determine renal epithelial-specific activity of this gene. Future studies utilizing transgenic animals may verify whether the activity of this 70-bp DNA fragment, examined in the cell culture model, demonstrates tubular epithelial specifity in the intact organism, where the transgene is exposed to a more physiologically relevant environment (i.e., hormones, proteins, etc.). Once established, it is possible that these transgenic animals will serve as an excellent model with which to study the transcriptional effects of a variety of physiological as well as pathophysiological factors on the paracellin-1 gene, and thus on tubular Mg 2ϩ reabsorption.
